Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis

• Market Cap: ₹67.01B
• Dividend Yield: N/A
• Average Volume (3M): 28.98K
• Price to Earnings (P/E): 42.5
• Beta (1Y): 1.04
• Revenue Growth: 27.65%
• EPS Growth: 4.02%
• Country: IN
• Employees: 3,607
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 4.30
• Shares Outstanding: 96,354,355
• 10 Day Avg. Volume: 38,534
• 30 Day Avg. Volume: 28,985
• PEG Ratio: 15.52
• Price to Book (P/B): 2.27
• Price to Sales (P/S): 4.14
• P/FCF Ratio: -22.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1,658.32
• Revenue Forecast (FY): ₹1.07T

• Rating: 66 Neutral
• Price Target: ₹764.00 ▲(9.85% Upside)

Yatharth Hospital's strong financial performance, characterized by revenue growth and improved profitability, is the most significant factor driving the stock score. However, technical indicators suggest short-term bearish momentum, and the high P/E ratio points to potential overvaluation. The absence of earnings call insights and corporate events limits the analysis to these core components.

Positive Factors

Revenue Growth

Sustained revenue growth indicates successful market penetration and service demand, supporting long-term business expansion.

Profitability

Improved profitability reflects efficient cost management and operational effectiveness, enhancing financial resilience.

Balance Sheet Health

A healthier balance sheet with reduced leverage increases financial stability and flexibility for future investments.

Negative Factors

Negative Free Cash Flow

Negative free cash flow can strain liquidity and limit the ability to fund new projects without additional financing.

Operational Efficiency

Declining EBIT margin indicates potential inefficiencies that could impact profitability if not addressed.

Over-Leverage Risk

Potential over-leverage could pose risks to financial stability, requiring careful management of asset growth.

Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model

Company Description

Yatharth Hospital & Trauma Care Services Limited owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of gynecology; gastroenterology; pulmonology; pediatric; nephrology and urology; cardiology; orthopedics and spine and rheumatology; neurosciences; medicine; general surgery; ENT; physiotherapy and rehabilitation; interventional spine and pain medicine; nutrition and health; pathology and laboratory medicine; dentistry; ophthalmology; dermatology; anesthesiology; radiology; and psychology and psychiatry. The company was incorporated in 2008 and is based in Noida, India.

How the Company Makes Money

Yatharth Hospital generates revenue primarily through patient services, which include inpatient admissions, outpatient consultations, surgeries, and diagnostic services. The hospital charges fees for various medical services rendered, which are often covered by health insurance plans, contributing significantly to its income. Additionally, YATHARTH may generate revenue through partnerships with insurance companies and government health programs that reimburse for treatments provided to insured patients. Other potential revenue streams could include ancillary services such as pharmacy sales, laboratory tests, and wellness programs. The hospital's focus on quality care and its reputation in the community also play crucial roles in attracting more patients and thereby increasing its earnings.

Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview

Summary

Yatharth Hospital shows strong revenue growth and improved profitability, with a high gross profit margin and a better debt-to-equity ratio. However, the negative free cash flow due to high capital expenditures indicates a need for careful investment management.

Income Statement

Yatharth Hospital has demonstrated strong revenue growth, with a significant increase from 2020 to 2025. The gross profit margin is consistently high, indicating efficiency in cost management. Net profit margin has improved, showcasing enhanced profitability. However, the slight drop in EBIT margin over the years suggests room for operational efficiency improvements.

Balance Sheet

The company's debt-to-equity ratio has improved significantly, reflecting a stronger equity base and reduced leverage. The substantial increase in stockholders' equity indicates robust growth in assets relative to liabilities. However, the high increase in total assets compared to liabilities suggests potential over-leverage if not managed properly.

Cash Flow

Operating cash flow has improved from negative to positive, signifying better cash management. However, free cash flow remains negative due to high capital expenditures, indicating ongoing investments in growth. The operating cash flow to net income ratio has improved, but sustaining this trend is crucial for long-term financial health.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	9.26B	8.80B	6.71B	5.20B	4.01B	2.29B
Gross Profit	6.25B	5.39B	5.37B	4.27B	3.20B	1.82B
EBITDA	2.53B	2.36B	1.96B	1.37B	1.13B	675.27M
Net Income	1.42B	1.31B	1.14B	657.68M	441.62M	181.60M
Balance Sheet
Total Assets	0.00	17.31B	10.19B	4.86B	4.26B	3.09B
Cash, Cash Equivalents and Short-Term Investments	5.15B	5.15B	2.39B	382.36M	120.31M	51.52M
Total Debt	0.00	115.86M	846.47M	2.67B	2.64B	1.93B
Total Liabilities	-16.37B	940.45M	1.45B	3.03B	3.09B	2.28B
Stockholders Equity	16.37B	16.05B	8.74B	1.83B	1.17B	724.55M
Cash Flow
Free Cash Flow	0.00	-1.61B	-964.43M	439.70M	468.01M	235.38M
Operating Cash Flow	0.00	1.50B	-30.78M	637.84M	599.35M	436.73M
Investing Cash Flow	0.00	-4.20B	-2.26B	-203.10M	-521.75M	-212.38M
Financing Cash Flow	0.00	5.19B	3.04B	-177.48M	-11.24M	-190.50M

Yatharth Hospital and Trauma Care Services Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 695.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Negative. The current price of 695.5 is below the 20-day moving average (MA) of 716.64, below the 50-day MA of 764.88, and above the 200-day MA of 619.69, indicating a neutral trend. The MACD of -23.29 indicates Positive momentum. The RSI at 35.52 is Neutral, neither overbought nor oversold. The STOCH value of 59.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:YATHARTH.

Yatharth Hospital and Trauma Care Services Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INDRAMEDCO	69 Neutral	₹44.81B	25.64	―	0.92%	6.51%	18.24%
HCG	67 Neutral	₹101.66B	279.95	―	―	17.58%	-38.20%
YATHARTH	66 Neutral	₹67.01B	42.49	―	―	27.65%	4.02%
KIMS	65 Neutral	₹264.69B	76.84	―	―	25.74%	1.41%
ASTERDM	62 Neutral	₹313.67B	92.75	―	0.83%	-36.14%	-93.99%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SHALBY	49 Neutral	₹20.67B	455.92	―	0.63%	11.49%	-91.65%

Yatharth Hospital and Trauma Care Services Limited Corporate Events

Yatharth Hospital Releases Q2 FY26 Financial Results

Yatharth Hospital & Trauma Care Services Limited has released its Q2 FY26 financial results through an investor presentation. This announcement is part of the company’s compliance with regulatory requirements and aims to inform stakeholders about its financial performance, potentially impacting its market positioning and investor relations.

Yatharth Hospital Appoints New Independent Director to Strengthen Board

Yatharth Hospital and Trauma Care Services Limited has appointed Mr. Ramesh Krishnan as an Additional Director (Non-Executive Independent) effective from November 5, 2025, for a five-year term, subject to shareholder approval. This strategic appointment is part of the company’s efforts to strengthen its board with experienced leadership, potentially enhancing its governance and strategic direction.

Yatharth Hospital Expands with New Subsidiary Operations

Yatharth Hospital & Trauma Care Services Limited has announced the commencement of operations for its subsidiary, MGS Infotech Research and Solutions Private Limited, located in Faridabad, Haryana. This strategic expansion is expected to enhance the company’s market position and revenue generation capabilities, aligning with its long-term business goals and providing increased value for stakeholders.

Yatharth Hospital’s 18th AGM Resolutions Approved

Yatharth Hospital & Trauma Care Services Limited successfully concluded its 18th Annual General Meeting on September 30, 2025, with all proposed resolutions approved by the requisite majority. The meeting was conducted via video conferencing, and the results, along with the Scrutinizer’s Report, have been disclosed in compliance with SEBI regulations. This development underscores the company’s commitment to transparency and effective governance, potentially strengthening its position in the healthcare industry.

Yatharth Hospital Announces 18th AGM with E-Voting Facility

Yatharth Hospital & Trauma Care Services Limited has announced the convening of its 18th Annual General Meeting (AGM) scheduled for September 30, 2025, to be held via video conferencing. The company is providing e-voting facilities to its members, allowing them to vote on resolutions prior to the meeting, reflecting its commitment to engaging stakeholders and adhering to regulatory requirements.